You are here

  • Home
  • Archive
  • Volume 80, Issue 2
  • Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: ‘COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs’ …

Article metrics

Article menu
Download PDFPDF
Correspondence response
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: ‘COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs’ by Conticini et al

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 2020591587243
Jun 202023323059
Jul 2020969614
Aug 2020414511
Sep 2020484221
Oct 2020323531
Nov 202026287
Dec 2020232311
Jan 202124323750
Feb 2021887942
Mar 2021756026
Apr 2021463830
May 2021444215
Jun 2021383216
Jul 2021434719
Aug 2021334114
Sep 2021374411
Oct 2021323731
Nov 2021253216
Dec 2021313510
Jan 2022333819
Feb 202250569
Mar 202230338
Apr 202229318
May 2022313613
Jun 2022262812
Jul 202223276
Aug 202230395
Sep 202234349
Oct 202227256
Nov 202212124
Dec 202219188
Jan 20238810
Feb 202338382
Mar 2023883
Apr 20231013
May 20232722
Jun 20231821
Jul 20232502
Aug 20231600
Sep 20231501
Oct 20231000
Nov 20233010
Dec 20233911
Jan 20242310
Feb 20242021
Mar 20241110
Total24672252810